Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant.
Journal Information
Full Title: Cell Transplant
Abbreviation: Cell Transplant
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Transplantation
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This article was supported by the National Natural Science Foundation of China (81900186) and the Tianjin Municipal Science and Technology Commission Grant (21JCQNJC00070)."
"Ethical Approval: This study was approved by the Medical Ethics Committee of the Tianjin First Center Hospital (Tianjin, China).: This Clinical trial is registered at http://www.chictr.org.cn/index.aspx as ChiCTR-ONN-16009862 and http://www.chictr.org.cn/index.aspx as ChiCTR1800019622."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025